Sanner Rebranded Gilero and Expanded Chicago Facility
The expansion gives medical device operators new access to rapid prototyping and specialized laboratory equipment.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Does the consolidation of medical device manufacturers into larger entities ultimately benefit the healthcare industry?
Sanner has rebranded its 2024 acquisition, Gilero, under the Sanner name while simultaneously expanding its Chicago innovation center. The move aims to integrate medical device development with pharmaceutical packaging services for North American customers.
Why it matters
The investment embeds Sanner within the Chicago medtech ecosystem, providing operators a single-source platform for device prototyping and compliance testing. This integration is designed to accelerate the product development cycle by consolidating human factors design and manufacturing.
Sanner maintains a workforce of more than 850 people globally and supplies products to 150 countries. The firm operates manufacturing sites across Germany, France, Hungary, China, and the US.
The players
Sanner
A global manufacturer of pharmaceutical packaging and medical devices founded in 1894.
GHO Capital
A healthcare-focused private equity firm that acquired a majority stake in Sanner in 2021.
mHUB
A Chicago-based innovation center providing specialized manufacturing and testing equipment for startups and enterprises.
The details
The upgraded Chicago location introduces a human factors laboratory and rapid prototyping capabilities directly linked to the mHUB Innovation Center. Operators can now utilize on-site advanced testing tools, including laser cutting, CT scanning, and selective laser sintering 3D printing. By merging these technical services with its existing packaging expertise, the company aims to streamline the transition from initial design to market-ready production.
Timeline
Sanner was founded in 1894.
GHO Capital acquired a majority stake in Sanner in November 2021.
Sanner acquired Gilero in 2024.
Market Landscape
The expansion follows the growth strategy established after the 2021 acquisition of Sanner by GHO Capital. This consolidation reflects a broader trend among medical device firms to secure internal end-to-end capabilities, from human-centered design to high-volume manufacturing.
Operators in the medical device space should monitor how this integrated service model impacts project turnaround times in the Midwest. Companies currently outsourcing prototyping and testing may find that consolidated platforms simplify procurement and compliance documentation.
The takeaway
Integrated manufacturing and design platforms are increasingly becoming the standard for medical device developers looking to reduce time-to-market. Keep a close watch on the throughput capabilities of local innovation centers as peer firms consolidate similar development services.
Further reading
For more on industry developments, visit the Healthcare section.
Source note: This article includes information reported by PlasticsToday.
Live Poll
Does the consolidation of medical device manufacturers into larger entities ultimately benefit the healthcare industry?
